Five Prime Therapeutics, Inc. (Nasdaq: FPRX), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today announced that Aron Knickerbocker, Chief Executive Officer, will present at the 2018 Wells Fargo Healthcare Conference, Sept. 6, 2018, at 2:30 pm
August 30, 2018
· 1 min read